Details of the Drug Formulations

General Information of Drug (ID: DMUL5EW)

• Drug Name: Posaconazole Drug Info
• Synonyms: Noxafil; Spriafil; Posaconazole SP; Posaconazole in combination with MGCD290; SCH56592; Sch 56592; X2N; Noxafil (TN); Noxafil, Posaconazole; SCH-56592; Posaconazole (USAN/INN); Posaconazole [USAN:INN:BAN]; 1-((1S,2S)-1-Ethyl-2-hydroxypropyl)-4-{4-[4-(4-{[(5S,3R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazolylmethyl)oxolan-3-yl]methoxy}phenyl)piperazinyl]phenyl}-1,2,4-triazolin-5-one; 4-(p-(4-(p-(((3R,5R)-5-(2,4-Difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furyl)methoxy)phenyl)-1-piperazinyl)phenyl)-1-((1S,2S)-1-ethyl-2-hydroxypropyl)-delta(sup 2)-1,2,4-triazolin-5-one; 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one; 4-[4-[4-[4-[[(5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one

Indication

Disease Entry	ICD 11	Status	REF
Aspergillosis	1F20	Approved	[1]
Candidiasis	1F23	Approved	[2]
Chromomycosis		Approved	[2]
Coccidioidomycosis	1F25	Approved	[2]
Fusariosis		Approved	[2]

• Therapeutic Class: Antifungal Agents
• Cross-matching ID:
  PubChem CID: 468595
  ChEBI ID: CHEBI:64355
  CAS Number: 171228-49-2
  TTD ID: D07ABV
  VARIDT ID: DR00111
  INTEDE ID: DR1316
  ACDINA ID: D00542

Full List of Drug Formulations Containing This Drug

Posaconazole 100 mg tablet

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F17365	Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Silicon dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose acetate succinate 06081224 (3 mm2/s); Microcrystalline cellulose; Polyvinyl alcohol, unspecified

References

• [1] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 022003.
• [2] Posaconazole FDA Label